Personally I think Constellation will float it as soon as possible and hope the milestones are not meet giving them the out they need while cleaning up from the float . If it does meet the milestones it's even a bigger winner for them bearing in mind they are paying next to nothing for it . I might be wrong but I personally have a feeling something's coming from the US . Wayne did not go there to talk to and attract retail investors . Maybe there is a TAVR deal in the wind be at a discounted rate with some upfront payment , . Who knows ? For me this is just a big punt but I know for a lot investors out there you have coped huge losses if the SP stays where it is . I am still making a good earn even at 6 c but I am not selling this time like I did before . I am prepared to ride this one and see we're it ends up . Really doing what I am doing here goes completely against my beliefs in investing in biotechs , I like to see 12 mths funding ahead in the bank , waiting till your low on cash is not a good position to do a CR from , As for if the deal with Constellation does or does not go ahead probably makes no difference AHZ will just have to wind that up for the time being . There was never any cash for the TAVR side of things in the deal so I can't see any substantial loss . I agree with you getting rid of it lets them focus on marketing CC and VC (this is hugely important ) and could be the life blood for AHZ . .Hopefully the ADAPT sales can ultimately put the company into a cash flow positive situation so the TAVR valve can move forward . For the moment it's no use worrying about something we have no knowledge or control over .
AHZ Price at posting:
6.0¢ Sentiment: Hold Disclosure: Held
(20min delay)